Adverum Biotechnologies, Inc.
Prognozy (mln)
| Okres |
2024-12-31 |
2025-12-31 |
2026-12-31 |
2027-12-31 |
2028-12-31 |
2029-12-31 |
| Przychód (średnia) |
1.00 |
15.19 |
15.18 |
35.29 |
24.23 |
78.89 |
| Przychód Δ r/r |
0.00% |
1419.00% |
-0.06% |
132.44% |
-31.32% |
225.56% |
| Przychód (min) |
1.00 |
15.19 |
15.18 |
35.29 |
24.23 |
78.89 |
| Przychód (max) |
1.00 |
15.19 |
15.18 |
35.29 |
24.23 |
78.89 |
| EBITDA (średnia) |
-0.20 |
-3.04 |
-3.04 |
-7.06 |
-4.85 |
-15.78 |
| EBIT (średnia) |
-0.20 |
-3.04 |
-3.04 |
-7.06 |
-4.85 |
-15.78 |
| EBIT % |
-20.00% |
-20.00% |
-20.00% |
-20.00% |
-20.00% |
-20.00% |
| Zysk netto (średni) |
-97.46 |
-112.82 |
-63.90 |
-65.78 |
-61.82 |
-35.21 |
| Zysk netto % |
-9745.59% |
-742.75% |
-420.95% |
-186.41% |
-255.10% |
-44.63% |
| EPS (średnia) |
-5.00 |
-5.70 |
-3.16 |
-3.41 |
-3.12 |
-1.78 |
| Liczba analityków (Przychody) |
6 |
3 |
6 |
4 |
2 |
3 |
| Liczba analityków (EPS) |
6 |
5 |
5 |
4 |
3 |
2 |
| symbol |
ADVM |
ADVM |
ADVM |
ADVM |
ADVM |
ADVM |